Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.084 INR | -0,74% | +1,84% | +52,19% |
Omzet 2024 * | 8,45 mld. 101 mln. 94,7 mln. | Omzet 2025 * | 10,78 mld. 129 mln. 121 mln. | Marktkapitalisatie | 55 mld. 660 mln. 617 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 908 mln. 10,89 mln. 10,18 mln. | Nettowinst (verlies) 2025 * | 1,42 mld. 17,06 mln. 15,94 mln. | EV/omzet 2024 * | 6,39 x |
Nettoliquiditeiten 2024 * | 1,06 mld. 12,67 mln. 11,84 mln. | Nettoliquiditeiten 2025 * | 1,2 mld. 14,36 mln. 13,42 mln. | EV/omzet 2025 * | 4,99 x |
K/w-verhouding 2024 * |
60,1
x | K/w-verhouding 2025 * |
38,8
x | Werknemers | 838 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 26,03% |
Recentste transcriptie over Orchid Pharma Limited
1 dag | -0,74% | ||
1 week | +1,84% | ||
Lopende maand | +3,78% | ||
1 maand | +3,10% | ||
3 maanden | +52,09% | ||
6 maanden | +132,24% | ||
Lopend jaar | +52,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31-03-20 |
Director of Finance/CFO | - | 29-06-20 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 74 | 31-03-20 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 31-03-20 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31-03-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1.084 | -0,74% | 63 987 |
25-04-24 | 1.092 | +2,57% | 52 477 |
24-04-24 | 1.065 | +0,84% | 44 385 |
23-04-24 | 1.056 | +0,25% | 59 388 |
22-04-24 | 1.054 | -1,06% | 71 798 |
uitgestelde koers NSE India S.E., 26 april 2024 om 13:43 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,19% | 659 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |